Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Move comes amid rising regulatory pressures
Targets high-growth eye care expansion push
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The conclave brought together over 1,000 delegates from across India and internationally
Subscribe To Our Newsletter & Stay Updated
